Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.22.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Current Assets        
Accounts and Notes Receivable, Allowances $ 10.2 $ 9.7    
Shareholders' Equity        
Common Stock, Shares Authorized (in Shares) 200,000,000 200,000,000    
Common Stock, Par Value (in Dollars per Share) $ 0.75 $ 0.75    
Common Stock, Shares Issued (in Shares) 102,538,000 102,538,000    
Common Stock, Shares Outstanding 71,365,000 76,933,000    
Treasury Stock, Shares (in Shares) 31,173,000 25,605,000 24,663,000 22,969,000